๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Seroprevalence of anti-Chlamydia trachomatisIgG in outpatients attending a sexually transmitted disease clinic in Italy

โœ Scribed by E. Paroli; E. Franco; A. Mele; F. Caprilli; G. Gentili; M. A. Stazi; R. Corona; F. Felici; G. Prignano; G. Palamara; P. Pasquini; A. Pana


Publisher
Springer
Year
1990
Tongue
English
Weight
240 KB
Volume
6
Category
Article
ISSN
0393-2990

No coin nor oath required. For personal study only.

โœฆ Synopsis


Prevalence of anti-Chlamydia trachomatis specific IgG antibodies was evaluated in a sexually transmitted disease outpatient population composed of 741 heterosexuals, 470 males and 271 females, and of 147 homosexual-bisexual men. The prevalence rates were 60.0% in heterosexual males, 50.6% in females and 73.5% in homosexuals-bisexuals. A positive association between age and antibody prevalence was found in males. Among heterosexuals there is an increasing trend of seropositivity with number of partners during the previous year. A significant association between anti-chlamydial and anti-herpes simplex, type 2, antibodies has been demonstrated.


๐Ÿ“œ SIMILAR VOLUMES


Genital herpes infection in outpatients
โœ A. Mele; E. Franco; F. Caprilli; G. Gentili; B. Capitanio; E. Crescimbeni; A. Na ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 230 KB

Prevalence of Herpes Simplex, type 2, specific antibodies .was estimated in sexually transmitted disease outpatients: 783 heterosexuals and 158 homosexualbisexuals. The anti-HSV-2 prevalence rates were 69% in the homosexuaPbisexuals and 35% in the heterosexuals. In both groups positive association w

Risk factors for hepatitis B virus infec
โœ Corona, Rosamaria; Caprilli, Federico; Giglio, Amalia; Stroffolini, Tommaso; Tos ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 465 KB ๐Ÿ‘ 2 views

The seroprevalence and risk factors for hepatitis B virus (HBV) infection were determined among 1,497 heterosexuals with no history of intravenous drug use (median age 32, range 15-78) treated at a sexually transmitted disease clinic in Rome. A total of 329 (22.0%) had antibodies to HBV core antigen